Cargando…
Correction: Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy
Autores principales: | Brody, A. Harrison, Nies, Sarah Helena, Guan, Fulin, Smith, Levi M., Mukherjee, Bandhan, Salazar, Santiago A., Lee, Suho, Lam, Tu Kiet T., Strittmatter, Stephen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426029/ https://www.ncbi.nlm.nih.gov/pubmed/36038879 http://dx.doi.org/10.1186/s13024-022-00557-5 |
Ejemplares similares
-
Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy
por: Brody, A. Harrison, et al.
Publicado: (2022) -
Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
por: Rawat, Priyanka, et al.
Publicado: (2022) -
VPS35 regulates tau phosphorylation and neuropathology in tauopathy
por: Vagnozzi, Alana N., et al.
Publicado: (2021) -
LRRK2 phosphorylates novel tau epitopes and promotes tauopathy
por: Bailey, Rachel M., et al.
Publicado: (2013) -
Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy
por: Tang, Si Jie, et al.
Publicado: (2020)